The year 2022 has been full of innovations in the management of borderline or locally advanced pancreatic adenocarcinoma and offers new opportunities for multimodal treatments at the Cliniques universitaires Saint Luc. Here, we illustrate the importance of multidisciplinary management for this type of patients through two clinical cases. We then detail the innovations and specificities regarding the different medical specialties, whose expertise is crucial within the group.
Key Words
Cancer, adenocarcinoma, pancreas, chemotherapy, radiotherapy, neoadjuvant treatment, surgery, complete pathological response